Drug Discovery: Design and Serendipity

Principles and Practice of Pharmaceutical Medicine, Second Edition

Volumn , Issue , 2007, Pages 43-50

  Cobb, Ronald R ^a   Molony, Leslie J ^a  

^a RiverWood BioConsulting Inc   (United States)

Author keywords

'unmet clinical need' as market niche; Drug discovery design and serendipity; Drug discovery and development; Drug discovery project designing; Pharmacognosy

Indexed keywords

EID: 67649315979     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470093153.ch4     Document Type: Chapter

References (18)

1. Amersham Life Science. 1993. Brochure on scintillation. Drug Discovery proximity assays. Publication No. S 593/657/4/93/09. Amersham International.
2. Beeley LJ, Duckworth DM. 1996. The impact of genomics on drug design. Drug Discov. Today 1(11): 474-480.
3. Chapman D. 1996. The measurement of molecular diversity: a three dimensional approach. J. Comput.-Aided Mol. Des. 10: 501-512.
4. Goffeau A, et al. 1996. Life with 6000 genes. Science 274: 546-567.
5. Kozlowski MR. 1996. Problem solving in laboratory automation. Drug Discov. Today 1(11): 481-488.
6. Lipinski CA, et al. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23: 3-29.
7. Lipper RA. 1999. How can we optimize selection of drug development candidates from many compounds at the discovery stage? Mod. Drug Discov. 2(1): 55-60.
8. Pericak-Vance MA, Bebout JL, Gaskell PC, et al. 1991. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48: 1034-1050.
9. Schuler GD, et al. 1996. A gene map of the human genome. Science 274: 540-546.
10. Van Drie JH. 1997. Strategies for the determination of pharmacophoric 3D database queries. J. Comput.-Aided Mol. Des. 11: 39-52.
11. Wainer IW. 1993. Stereoisomers in clinical oncology: why it is important to know what the right and left hands are doing. Ann. Oncol. 4(Supp 2): 7-13.
12. Beeley LJ, Duckworth DM. 1996. The impact of genomics on drug design. Drug Discov. Today 1(11): 474-480.
13. Bugrim A, Nikolskaya T, Nikolsky Y. 2004. Drug Discov. Today 9: 127-135.
14. Chapman D. 1996. The measurement of molecular diversity: a three dimensional approach. J. Computer-Aided Mol. Des. 10: 501-512.
15. Downward J. 2002. Targeting RAS signaling pathways in cancer therapy. Nat. Rev.: Cancer 3: 11-21.
16. Goffeau A, et al. 1996. Life with 6000 genes. Science 274: 546-567.
17. Kozlowski MR. 1996. Problem solving in laboratory automation. Drug Discov. Today 1(11): 481-488.
18. Schuler GD, et al. 1996. A gene map of the human genome. Science 274: 540-546.